Michael Ryskin
BofA Securities, Research Division

My name is Mike Ryskin. I'm on the Bank of America Life Science Tools and Diagnostics team. And we're excited to be hosting West Pharmaceutical Services for our next chat, joined by Eric Green, President and CEO; and Bob McMahon, Chief Financial Officer.

Eric, Bob, thanks so much for being here.

Eric Green
Non-Independent Chair of the Board, President & CEO

Great. Thank you for hosting us.

Michael Ryskin
BofA Securities, Research Division

Of course. Thanks for being here. Format will be a fireside chat Q&A. As usual, if you've got questions, feel free to raise your hand, and we'll incorporate you in. Standard opening question, but we're going to pivot a little bit, just given the 8-K last night on the cybersecurity issue. I kind of have to lead off with that. Just curious what's your response to that and sort of give us a quick rundown of the situation.

Eric Green
Non-Independent Chair of the Board, President & CEO

Yes. Let me start with this, and Bob, if you want -- so last night, we did issue an 8-K and what has happened is back last -- early last week, we had noticed that intrusion into our systems. We followed protocol, quickly shut down all our systems across the globe so that we can better understand the situation that was at hand.

On May 7, which is last Thursday, we identified that it was -- identified the intruder, identified that they had access to some of our